These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30572945)

  • 1. Distinct promoter methylation profile reveals spatial epigenetic heterogeneity in 2 myeloma patients with multifocal extramedullary relapses.
    Yao Q; Morgan GJ; Chim CS
    Clin Epigenetics; 2018 Dec; 10(1):158. PubMed ID: 30572945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability.
    Derrien J; Guérin-Charbonnel C; Gaborit V; Campion L; Devic M; Douillard E; Roi N; Avet-Loiseau H; Decaux O; Facon T; Mallm JP; Eils R; Munshi NC; Moreau P; Herrmann C; Magrangeas F; Minvielle S
    Genome Med; 2021 Aug; 13(1):127. PubMed ID: 34372935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of the MIR34B/C in multiple myeloma.
    Wong KY; Yim RL; So CC; Jin DY; Liang R; Chim CS
    Blood; 2011 Nov; 118(22):5901-4. PubMed ID: 21976676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in multiple myeloma: From mechanisms to therapy.
    Alzrigat M; Párraga AA; Jernberg-Wiklund H
    Semin Cancer Biol; 2018 Aug; 51():101-115. PubMed ID: 28962927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of the bone morphogenetic protein 6 gene in multiple myeloma.
    Hashida Y; Nemoto Y; Imajoh M; Murakami M; Taniguchi A; Komatsu N; Yokoyama A; Daibata M
    Oncol Rep; 2012 Mar; 27(3):825-30. PubMed ID: 22086350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
    Chim CS; Liang R; Leung MH; Kwong YL
    J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
    Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI
    Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma.
    de Carvalho F; Colleoni GW; Almeida MS; Carvalho AL; Vettore AL
    Int J Cancer; 2009 Oct; 125(8):1985-91. PubMed ID: 19548309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approach.
    Chim CS; Kwong YL; Liang R
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):331-9. PubMed ID: 19064397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
    Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
    Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.
    Wong KY; Li Z; Zhang X; Leung GK; Chan GC; Chim CS
    Mol Cancer; 2015 Sep; 14():175. PubMed ID: 26410378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chim CS
    J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
    Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
    Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific histone signature and DNA methylation in multiple myeloma and leukemia cells.
    Foltankova V; Legartova S; Kozubek S; Bartova E
    Neoplasma; 2012; 59(4):450-62. PubMed ID: 22489701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
    Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
    Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
    Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of specific genetic and epigenetic variables in multiple myeloma.
    Hatzimichael E; Dasoula A; Benetatos L; Syed N; Dranitsaris G; Crook T; Bourantas K
    Leuk Lymphoma; 2010 Dec; 51(12):2270-4. PubMed ID: 21067440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma.
    Benetatos L; Dasoula A; Hatzimichael E; Georgiou I; Syrrou M; Bourantas KL
    Clin Lymphoma Myeloma; 2008 Jun; 8(3):171-5. PubMed ID: 18650181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.
    Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
    Tumour Biol; 2016 Apr; 37(4):4603-12. PubMed ID: 26508024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.